Skip to main content
eScholarship
Open Access Publications from the University of California

HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial

  • Author(s): Glidden, David
  • Wong, Joseph
  • Grant, Robert
  • Liegler, T
  • Abdel-Mohsen, M
  • Bentley, LG
  • Atchison, R
  • Schmidt, T
  • Javier, J
  • Mehrotra, M
  • Eden, C
  • Glidden, DV
  • McMahan, V
  • et al.

Published Web Location

http://europepmc.org/articles/PMC4176446?pdf=render
No data is associated with this publication.
Abstract

© The Author 2014.Background: The iPrEx study demonstrated that combination oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) as preexposure prophylaxis (PrEP) protects against HIV acquisition in men who have sex with men and transgender women

Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.

Item not freely available? Link broken?
Report a problem accessing this item